The largest database of trusted experimental protocols

Immunoseq survey level assay

Manufactured by Adaptive Biotechnologies
Sourced in United States

The ImmunoSEQ survey level assay is a DNA sequencing-based tool developed by Adaptive Biotechnologies. It is designed to provide a comprehensive overview of the adaptive immune repertoire, including the identification and quantification of T-cell and B-cell populations.

Automatically generated - may contain errors

5 protocols using immunoseq survey level assay

1

CSF Immunoglobulin Variable Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA isolation and cDNA synthesis from CSF cell pellets were performed using the μMACS One-step cDNA Kit (Miltenyi Biotec) according to the manufacturer’s instructions. Synthesised cDNA was eluted from the column and collected with 50 µL cDNA elution buffer. Immunoglobulin Kappa Variable (IGKV) and Immunoglobulin Lambda Variable (IGLV) sequencing of cDNA were performed by Adaptive Biotechnologies (Seattle, Washington, USA) using the immunoSEQ survey level assay.
+ Open protocol
+ Expand
2

TCRβ Sequencing of Tumor and Spleen

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors and spleens were isolated 14 days after tumor injection followed by genomic DNA extraction using the DNeasy Blood and Tissue Kit (QIAGEN) according to manufacturer’s protocol. TCRβ sequencing was performed using the ImmunoSEQ survey level assay (Adaptive Biotechnologies). Sequencing data were analyzed using the ImmunoSEQ analyzer (Adaptive Biotechnologies) and the Vegan package in R.
+ Open protocol
+ Expand
3

Analyzing Tumor Infiltrating T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 14 after tumor inoculation, B16F10 tumors and spleens were isolated. Genomic DNA was extracted using the DNeasy Blood and Tissue Kit (QIAGEN). TCRβ sequencing was performed using the ImmunoSEQ survey level assay (Adaptive Biotechnologies). Sequencing data was analyzed using the ImmunoSEQ analyzer (Adaptive Biotechnologies).
+ Open protocol
+ Expand
4

Isolation and Sequencing of CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor genomic DNA was extracted using the DNeasy Blood and Tissue Kit (Qiagen). CD8α+ R9F-specific T cells were purified by FACS using R9F-dextramer reagent, anti-CD8α and anti-CD3. The cells were pelleted, frozen at -80 °C and sent to Adaptive Biotechnologies. The TCRβ locus was sequenced using the ImmunoSEQ survey level assay by Adaptive Biotechnologies (Seattle, WA). TCRβ sequencing was analyzed using the ImmunoSEQ Analyzer (Adaptive Biotechnologies).
+ Open protocol
+ Expand
5

CSF and Blood Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected between 20 and 25 ml CSF by lumbar puncture and approximately 60 ml blood by venipuncture at each time point. Mononuclear cells were isolated, and samples were prepared as previously described (Johansen, Vartdal, 2015) . Multiplex PCR of IGHV cDNA and high-throughput sequencing on the Illumina MiSeq system were performed by Adaptive Biotechnologies (USA) using the immunoSEQ survey level assay (coverage £ 100,000 B cells) (Larimore et al., 2012) . The survey level depth was chosen for both CSF and blood mononuclear cells in order to make valid comparisons across the two compartments. The sequencing raw data were preprocessed and normalized as previously described (Johansen, Vartdal, 2015) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!